- Company Directors - P
- Pappas Arthur M
Insider Trading History of Pappas Arthur M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Pappas Arthur M since 2006.
The trader's CIK number is 1189543.
At the time of the last reporting, Pappas Arthur M was the Director of Chimerix Inc. (stock ticker symbol CMRX).
Also see all insider trading activities at Chimerix Inc.
Note that in the past
PAPPAS ARTHUR M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Chimerix Inc (CMRX) by Pappas Arthur M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | CMRX | 0 | $0 | 216,840 | $3,363,188 | 0 | $0 |
Yearly summary of insider trading at Atherogenics Inc (AGIX) by Pappas Arthur M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | AGIX | 8,000 | $111,455 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Pappas Arthur M:
1. Chimerix Inc (CMRX)
2. Atherogenics Inc (AGIX)
Table 1. Insider trading of Chimerix Inc (CMRX) by Pappas Arthur M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-10-23 | CMRX | Sale | 216,840 | 15.51 | 3,363,188 |
Table 2. Insider trading of Atherogenics Inc (AGIX) by Pappas Arthur M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-05-24 | AGIX | Buy | 1,000 | 12.97 | 12,969 |
| 2006-05-22 | AGIX | Buy | 3,000 | 13.52 | 40,569 |
| 2006-04-27 | AGIX | Buy | 3,000 | 14.03 | 42,090 |
| 2006-03-24 | AGIX | Buy | 1,000 | 15.83 | 15,827 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pappas Arthur M
(Director of Chimerix Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.